Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Licia Mota and Ricardo Xavier.
Licia Mota
Connection Strength
0.346
Ricardo Xavier
  1. Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort. Clin Exp Rheumatol. 2021 Jul 07.
    View in: PubMed
    Score: 0.060
  2. Effects of Participating in a Research Project During the COVID-19 Pandemic on Medical Students' Educational Routines and Mental Health: Protocol for a Web-Based Survey Study. JMIR Res Protoc. 2021 04 09; 10(4):e24617.
    View in: PubMed
    Score: 0.059
  3. High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry. RMD Open. 2021 01; 7(1).
    View in: PubMed
    Score: 0.058
  4. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc. 2020 Dec 15; 9(12):e24357.
    View in: PubMed
    Score: 0.057
  5. Impact of Chronic Use of Antimalarials on SARS-CoV-2 Infection in Patients With Immune-Mediated Rheumatic Diseases: Protocol for a Multicentric Observational Cohort Study. JMIR Res Protoc. 2020 Oct 14; 9(10):e23532.
    View in: PubMed
    Score: 0.057
  6. Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Adv Rheumatol. 2020 06 09; 60(1):32.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.